William Douglas Young
Independent Non-Executive DirectorDr. William Douglas Young, also known as Bill, Ph. D. has been Director at SFJ Pharmaceuticals, Inc. Dr. Young is a Senior Advisor at Blackstone Life Sciences since November 2018. Previously, he had been Venture Partner at the firm since joining in March 2010. He serves as Independent Non-Executive Director at Autolus Therapeutics plc since November 6, 2021. He served as Consultant of BioMarin Pharmaceutical Inc. from November 12, 2015 to June 30, 2016. He has extensive experience in leadership roles within major life sciences and pharmaceutical companies. He serves as an Independent Director of Praxis Precision Medicines, Inc. since December 2016 and SJF Pharmaceuticals Inc. Dr. Young served as the Chief Executive Officer of Monogram Biosciences, Inc. (formerly, Monogram Incorporated) from November 1999 to August 4, 2009. He served as the Chief Operating Officer of Genentech, Inc. from 1997 to October 1999, was responsible for all of the biotechnology company?s development, operations and commercial functions, taking on responsibility for all development, operations and sales and marketing activities. From 1980 to 1999, he held various positions of increasing responsibility at Genentech, Inc. From 1966 to 1980, Dr. Young served as Executive Officer at Eli Lilly and Company. Dr. Young joined Genentech, Inc. in 1980 as Director of Manufacturing and Process Sciences and also served as the Vice President since 1983. He served as an Executive Vice President of Genentech, Inc. since 1996. Dr. Young served in production and process engineering & production management at Eli Lilly. He served as the Chairman of Annexon Inc. since March 9, 2017 until February 05, 2021 and served as its Independent Director since December 2014 until February 05, 2021. He serves as Independent Director at NS Wind Down Co., Inc. (formerly known as NanoString Technologies, Inc.) since October 2022 and also served as Independent Chairman since January 2010 until October 2022. He serves as the Chairman of Agy Therapeutics Inc. He served as Chairman of TYRX, Inc. Dr. Young is a Trustee of Montage Health. He serves as the Chairman of BayBio. Dr. Young served as the Chairman of Monogram Biosciences, Inc. from May 1999 to August 4, 2009. He was a Venture Partner at Claris Ventures from March 2010 until 2018. Dr. Young served as the Independent Chairman of Biogen Inc. (alternate name, Biogen Idec Inc.) from January 1, 2010 to June 12, 2014. He served as the Chairman of the Board of Raven Biotechnologies, Inc. until December 2007. He served as Chairman at Bay Area Bioscience Association. Dr. Young has been a Director of Agy Therapeutics Inc. since 2000. He has been a Director of BayBio since May 1997. He served as an Independent Director of Vertex Pharmaceuticals Incorporated since May 7, 2014 until June 03, 2020. He has been a Director of Ariosa Diagnostics, Inc. since May 2010. He had been Lead Independent Director of Theravance Biopharma, Inc. since April 2014 and had been its Independent Director since October 2013 until May 02,2023. He served as an Independent Director of BioMarin Pharmaceutical Inc. from September 22, 2010 to November 2015. He served as a Director of Innoviva, Inc. (alternate name, Theravance Inc.) from April 2001 to June 2, 2014. He served as a Director of Biogen MA Inc. (alternate name, Biogen Idec MA Inc.) from 1997 to June 12, 2014. He served as a Director of Biogen Inc. from May 1997 to June 12, 2014. He served as a Director of Raven Biotechnologies, Inc. He is currently chairman of the board and chief executive officer of ViroLogic, Inc. He served as a Director of Monogram Biosciences, Inc. until August 4, 2009. Dr. Young served as a Director of VaxGen Inc. from November 1995 to July 2004. He served as an Independent Director of Human Genome Sciences Inc. since September 17, 2003. Dr. Young served as a Director of Enchira Biotechnology Corporation since 1994. He was elected to the National Academy of Engineering in 1993 for his contributions to biotechnology. Dr. Young joined Clarus Ventures LLC in March 2010 and held various roles, including Venture Partner, Senior Advisor and portfolio company Board member. In 2000, Purdue University awarded Dr. Young an Honorary Doctorate of Engineering from Purdue University. He holds an M.B.A. from Indiana University and a B. S. in Chemical Engineering from Purdue University.
Positions
- Company NameAutolus Therapeutics plcStock CodeAUTLPositionIndependent Non-Executive DirectorColleagues
- CMChristian Martin ItinCEO & Director
- MWMichael Weston BonneyIndependent Chairman of the Board
- MPMartin PuleFounder, Senior VP & Chief Scientific Officer
- RFRobert F. DolskiSenior VP & CFO
- CVChristopher VannSenior VP & COO
- PMPatrick McIlvennySenior VP of Finance, Chief Accounting Officer & Principal Accounting Officer
- LCLinda Cathavina BainIndependent Non-Executive Director
- CMCynthia Marie ButittaIndependent Non-Executive Director
- Company NamePraxis Precision Medicines, Inc.Stock CodePRAXPositionIndependent DirectorColleagues
- MSMarcio Silva De'SouzaPresident, CEO & Director
- DJDean Jonathan MitchellIndependent Chairman of the Board
- TETimothy Edwin KellyCFO & Treasurer
- ANAlex NemiroffGeneral Counsel & Secretary
- SPSteven PetrouCo-Founder and President of Research & Development
- MTMegan T. SniecinskiChief Operating Officer
- WDWilliam Douglas YoungIndependent Director
- GNGregory NordenIndependent Director
- JAJeffrey Allan ChodakewitzIndependent Director
